Navigation Links
PEAK Surgical Announces Positive Results From Preclinical Study of PEAK PlasmaBlade(TM) for Obstetric and Gynecologic Surgery
Date:5/6/2008

study, freshly excised human abdominal tissue was cut using the PEAK PlasmaBlade, an uncoated traditional electrosurgery scalpel, a teflon-coated traditional electrosurgery scalpel and a fine wire and ceramic electrosurgery scalpel. Histology samples were immediately harvested to evaluate acute thermal tissue injury.

Also as part of the study, full-thickness skin incisions were made on porcine skin using a traditional electrosurgery device, the PEAK PlasmaBlade and a standard scalpel blade. Incisions were made at days 0, 21, 28, 35 and 42, and bleeding was evaluated for 60 seconds post-incision. The wounds were then sutured to allow for healing, and digital photos of the wounds were taken every seven days to evaluate scarring based on a visual analog scale. Histological examination was conducted to evaluate healing and inflammatory response.

Study Results

Histological evaluation of the ex vivo human skin showed that the PEAK PlasmaBlade cuts produced minimal collateral damage compared to cuts made with the other electrosurgery instruments.

In the porcine skin cuts, bleeding for 60 seconds following incision was reduced by 60 percent in the wounds made by the PEAK PlasmaBlade compared with those made by the standard scalpel (p=0.0001). Wound sections showed a 75 percent reduction in acute thermal damage with the PEAK PlasmaBlade compared with the traditional electrosurgery scalpel (p<0.03). After six weeks, there was no significant difference in scar formation between the PEAK PlasmaBlade and the standard scalpel; however, scarring was reduced by 66 percent with the PEAK PlasmaBlade compared with the traditional electrosurgery device (p<0.04). Staining for inflammatory cells showed significantly less infiltration in the wounds made by the standard scalpel and the PEAK PlasmaBlade, indicating less inflammation, compared with wounds made by the traditional electrosurgery device.

"Because of its ability to precisely cut tissue while c
'/>"/>

SOURCE PEAK Surgical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Anesiva Announces Pivotal Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Total Knee Replacement
2. Anesiva Commences Phase 3 Clinical Trial of Adlea(TM) for Reducing Post-Surgical Pain Following Bunionectomy
3. Innocoll Announces Dosing of First Patient in Second US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections
4. Ceremeds OSTENE(R) Stops Bone Bleeding Without Added Risk of Surgical Infection, New Study Finds
5. New Non-Surgical Stem-Cell Procedure to Relieve Chronic Tendon Problems
6. Portrait(R) Plasma - A New Non-Surgical Option for one of the Most Requested Aesthetic Treatment - Aging Eyes
7. Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) BUPIVACAINE SURGICAL IMPLANT for the Management of Post-operative Pain
8. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients
9. N30 Pharma Announces Completion of Phase 1 Clinical Studies With N30-201
10. Senetek PLC Announces Positive Results from Pyratine-6(TM) Clinical Trial in Patients with Acne Rosacea
11. Volcano Announces Participation in SATURN Clinical Trial Sponsored by AstraZeneca
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 23, 2014  Lockton Dunning Benefits, the ... Companies, announced the addition of Vice President ... Lockton Dunning,s Pharmacy Consulting team, Excelsior Solutions. ... industry experience to the position.  Most recently, she ... at Diplomat Specialty Pharmacy, where she has held ...
(Date:12/24/2014)... RALEIGH, N.C. , Dec. 23, 2014 /PRNewswire/ ... (NASDAQ: ENDP ) (TSX: ENL), and BioDelivery ... today that they have submitted a New Drug Application ... Food and Drug Administration (FDA).  Buprenorphine HCl Buccal Film ... enough to require daily, around-the-clock, long-term opioid treatment and ...
(Date:12/22/2014)... Dec. 22, 2014 Apnea Sciences ( www.apneasciences.com ... in Aliso Viejo , California.  ... the tremendous growth and worldwide expansion, a new facility ... SnoreRx, the anti snore cure have exceeded our expectations ... "We are now in 23 countries and will be ...
Breaking Medicine Technology:Kim Foerster Joins Lockton Companies 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5
... just-released National Minority Quality Forum Issue Brief (Specialty ... Gary Puckrein and Gretchen Wartman examine specialty tiering, ... private) as a benefit-management tool to limit their financial ... high-cost prescription drugs. The authors remind us that, the ...
... 10, 2011 Misonix, Inc. (NASDAQ: ... manufactures and markets innovative therapeutic ultrasonic products worldwide ... laparoscopic surgery, and other surgical and medical applications, ... debridement by adding their SonicOne® technology to the ...
Cached Medicine Technology:Prescription-Drug Plans' Use of Specialty Tiers Promotes Inequalities 2Misonix Announces Entry Into Surgical Wound Debridement 2Misonix Announces Entry Into Surgical Wound Debridement 3
(Date:12/25/2014)... December 26, 2014 The microscopy ... of 7.2% to reach $5,756.0 million by 2019. ... microscopy market. The electron microscopes product segment is ... forecast period. , Rising focus on nanotechnology, technological ... of the microscopy market. , Get Full Copy ...
(Date:12/25/2014)... 26, 2014 The click ... beauty, strength and durability. Today, the business announces ... is valid until Jan. 30, 2015. , Click ... traditional hardwood. BambooFlooringChina.com is a well-known brand in ... worldwide to find a reliable bamboo flooring supplier. ...
(Date:12/25/2014)... 2014 The report “TS-1 (Colorectal Cancer) ... the current treatment landscape, unmet needs, current pipeline and ... an anti-cancer drug which is typically used for treating ... used for treating gastric cancer and pancreatic cancer. TS-1 ... drug was first approved in 1999 in Japan for ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 “Every three months ... market changes. A-line sweetheart evening dress will be one of ... sales manager of Yunx.co.uk says. Today, the company releases 26 ... discounts, up to 80% off. , “We are trying ... unique style with our latest designs. Along with affordable prices, ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 Recently, Dylan ... dresses, has excitedly released its collection of discounted prom ... to Percy, a senior spokesman of the company, the ... of this promotion is to expand the UK market. ... in several different colors, lengths, and styles: A-line strapless, ...
Breaking Medicine News(10 mins):Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2
... Sky One,Medical, Inc. ("China Sky One Medical" or ... fully integrated pharmaceutical company producing over-the-counter,drugs in the ... it,successfully obtained the production approval from the State ... additional drugs: Sodium Cromoglicate,Eye Drops for the treatment ...
... Re Ltd., the reinsurance unit of White Mountains Insurance Group, Ltd. ... Financial Officer, will retire from full-time work at the end of ... advisor to White Mountains. , , ... the last 7 years Chuck has filled many roles within our ...
... PITTSBURGH, Dec. 16 MED3OOO, Inc., a national healthcare management, ... able to help the City of Newark, Ohio recover lost ... companies. , , After partnering ... of Newark Division Fire & EMS department is now able ...
... Dec. 16 CeloNova BioSciences, Inc., announced,today that ... U.S. Food and,Drug Administration (FDA) for Embozene(TM) Color-Advanced ... tumors (tumors with a,large number of blood vessels ... circulatory system). U.S. commercial sales of,Embozene(TM) Microspheres will ...
... Dec. 16 While all cosmetic surgery,can be performed ... feel or remember their surgery - a condition commonly ... (Photo: http://www.newscom.com/cgi-bin/prnh/20081216/LATU002 ) , ... iv sedation, pioneered by anesthesiologist Dr. Barry L.,Friedberg, is ...
... more efficiently, Fresho.com offers bulk job posting and announces new job ad ... ... NY (PRWEB) December 16, 2008 -- In order to help employers fill ... search engine Fresho.com now offers employers to submit their job openings ...
Cached Medicine News:Health News:China Sky One Medical, Inc. Obtains Production Rights for Two Additional Drugs 2Health News:China Sky One Medical, Inc. Obtains Production Rights for Two Additional Drugs 3Health News:White Mountains Re Announces Management Changes -- Chokel to Retire and Remain Risk Advisor at WTM 2Health News:White Mountains Re Announces Management Changes -- Chokel to Retire and Remain Risk Advisor at WTM 3Health News:White Mountains Re Announces Management Changes -- Chokel to Retire and Remain Risk Advisor at WTM 4Health News:City of Newark, Ohio Increases Safety Services with EMS Revenue Recovered by MED3OOO EMS Billing 2Health News:City of Newark, Ohio Increases Safety Services with EMS Revenue Recovered by MED3OOO EMS Billing 3Health News:CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform 2Health News:CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform 3Health News:CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform 4Health News:Cosmetic Surgery -'Goldilocks' Anesthesia Is Not Mickey Mouse 2Health News:Fresho.Com Offers Efficient Job Postings for Employers and Recruiters 2
... Performance ,MARS Technology is the next generation ... an addition to our current family of ... advantage of new technological breakthroughs in signal ... pulse signal resulting in superior performance during ...
The NPB-40 Handheld Pulse Oximeter is both compact and affordable. It is simple to operate, provides spot-check monitoring of SpO 2 and pulse rate, and is compact enough to fit in your pocket....
... The Nellcor N-20PA Handheld Pulse Oximeter is ... The durable construction of the N-20PA has ... temperatures and conditions it has even ... is conveniently portable for spot check measurements ...
... Nellcor's most popular handheld oximeter has been ... platform and is now compatible with the ... the MAX-FAST Forehead Sensor and SoftCare Nonadhesive ... Oximeter also incorporates Nellcor's latest advanced signal ...
Medicine Products: